Clinical Trial Update: A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

View source ↗

Summary

This clinical trial update reports on a safety and efficacy study of BOTOX (botulinum toxin type A) for urinary incontinence due to neurogenic detrusor overacti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence, Overactive Bladder | Status: COMPLETED